Catalent Inc (CTLT)
60.98
+1.32
(+2.21%)
USD |
NYSE |
Nov 22, 16:00
60.91
-0.07
(-0.11%)
After-Hours: 20:00
Catalent Cash from Investing (Quarterly): -34.00M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -34.00M |
| June 30, 2024 | -74.00M |
| March 31, 2024 | -74.00M |
| December 31, 2023 | -95.00M |
| September 30, 2023 | -84.00M |
| June 30, 2023 | -121.00M |
| March 31, 2023 | -110.00M |
| December 31, 2022 | -608.00M |
| September 30, 2022 | -116.00M |
| June 30, 2022 | -394.00M |
| March 31, 2022 | -191.00M |
| December 31, 2021 | -1.132B |
| September 30, 2021 | -167.00M |
| June 30, 2021 | -213.00M |
| March 31, 2021 | -82.00M |
| December 31, 2020 | -203.00M |
| September 30, 2020 | -151.00M |
| June 30, 2020 | -162.20M |
| March 31, 2020 | -465.60M |
| December 31, 2019 | -114.30M |
| September 30, 2019 | -84.90M |
| June 30, 2019 | -1.252B |
| March 31, 2019 | -48.90M |
| December 31, 2018 | -43.00M |
| September 30, 2018 | -165.80M |
| Date | Value |
|---|---|
| June 30, 2018 | -58.80M |
| March 31, 2018 | -34.80M |
| December 31, 2017 | -783.00M |
| September 30, 2017 | -42.70M |
| June 30, 2017 | -52.00M |
| March 31, 2017 | -118.50M |
| December 31, 2016 | -23.90M |
| September 30, 2016 | -114.60M |
| June 30, 2016 | -29.90M |
| March 31, 2016 | -25.30M |
| December 31, 2015 | -49.30M |
| September 30, 2015 | -33.20M |
| June 30, 2015 | -31.50M |
| March 31, 2015 | -43.90M |
| December 31, 2014 | -151.70M |
| September 30, 2014 | -44.70M |
| June 30, 2014 | -60.50M |
| March 31, 2014 | -24.70M |
| December 31, 2013 | -59.80M |
| September 30, 2013 | -26.20M |
| June 30, 2013 | -37.60M |
| March 31, 2013 | -31.90M |
| December 31, 2012 | -28.00M |
| September 30, 2012 | -24.60M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-1.132B
Minimum
Dec 2021
-34.00M
Maximum
Sep 2024
-229.56M
Average
-136.00M
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly and Co | -4.005B |
| Boston Scientific Corp | -1.427B |
| Pfizer Inc | -2.057B |
| Merck & Co Inc | -3.845B |
| Avid Bioservices Inc | -1.311M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 61.00M |
| Cash from Financing (Quarterly) | -10.00M |
| Free Cash Flow | 99.00M |
| Free Cash Flow Per Share (Quarterly) | 0.022 |
| Free Cash Flow to Equity (Quarterly) | -25.00M |
| Free Cash Flow to Firm (Quarterly) | 70.15M |
| Free Cash Flow Yield | 0.89% |